Jonathan Ee-ren Lim

Title: Innovations in Cancer Treatment by Jonathan Ee-ren Lim

Introduction

Jonathan Ee-ren Lim is a notable inventor based in San Diego, CA. He has made significant contributions to the field of cancer treatment through his innovative patents. With a total of 2 patents, Lim is dedicated to advancing medical science and improving patient outcomes.

Latest Patents

Lim's latest patents focus on combinations for the treatment of cancer. One patent describes combinations comprising a therapeutically effective amount of a first agent and a second agent, where the first agent is an inhibitor of ALK, ROS1, TrkA, TrkB, or TrkC activity. This patent outlines methods of using such combinations in the treatment of patients with cancer. Another patent discloses methods for treating cancer in subjects with genetic alterations in RET. This involves administering a therapeutically effective amount of a specific compound or its pharmaceutically acceptable salt.

Career Highlights

Lim is currently associated with Ignyta, Inc., a company focused on precision medicine for cancer treatment. His work at Ignyta has allowed him to explore innovative solutions that target specific genetic alterations in cancer patients. Lim's research is pivotal in developing new therapeutic strategies that can lead to better treatment options.

Collaborations

Some of Lim's notable coworkers include Gang Li and Ge Wei. Their collaborative efforts contribute to the advancement of cancer research and the development of effective treatment methodologies.

Conclusion

Jonathan Ee-ren Lim's contributions to cancer treatment through his patents reflect his commitment to innovation in medical science. His work continues to pave the way for new therapeutic approaches that can significantly impact patient care.